Barclays PLC lowered its holdings in RXO, Inc. (NYSE:RXO - Free Report) by 68.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 285,194 shares of the company's stock after selling 623,679 shares during the period. Barclays PLC owned approximately 0.18% of RXO worth $6,798,000 as of its most recent SEC filing.
Several other large investors also recently made changes to their positions in the business. Blue Trust Inc. increased its stake in RXO by 79.7% during the 4th quarter. Blue Trust Inc. now owns 1,150 shares of the company's stock worth $27,000 after buying an additional 510 shares during the period. Wilmington Savings Fund Society FSB purchased a new stake in shares of RXO during the third quarter worth about $28,000. Smartleaf Asset Management LLC grew its stake in RXO by 228.4% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,248 shares of the company's stock worth $30,000 after purchasing an additional 868 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. grew its stake in RXO by 407.0% in the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,800 shares of the company's stock worth $43,000 after purchasing an additional 1,445 shares in the last quarter. Finally, KBC Group NV grew its stake in RXO by 41.2% in the fourth quarter. KBC Group NV now owns 5,727 shares of the company's stock worth $137,000 after purchasing an additional 1,672 shares in the last quarter. Institutional investors and hedge funds own 92.73% of the company's stock.
RXO Price Performance
Shares of NYSE RXO traded up $0.36 during trading on Wednesday, hitting $14.06. The company had a trading volume of 1,618,166 shares, compared to its average volume of 1,156,464. The company has a market cap of $2.30 billion, a P/E ratio of -6.63, a PEG ratio of 4.55 and a beta of 1.60. RXO, Inc. has a 52 week low of $12.19 and a 52 week high of $32.82. The business's 50-day moving average is $16.83 and its 200 day moving average is $23.04. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.33 and a current ratio of 1.26.
RXO (NYSE:RXO - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.06 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.06. RXO had a positive return on equity of 1.53% and a negative net margin of 6.26%. Equities research analysts predict that RXO, Inc. will post 0.31 earnings per share for the current fiscal year.
Analysts Set New Price Targets
A number of equities analysts recently commented on the company. Stifel Nicolaus decreased their price target on RXO from $27.00 to $24.00 and set a "hold" rating for the company in a research note on Thursday, February 6th. Truist Financial decreased their target price on RXO from $24.00 to $19.00 and set a "buy" rating for the company in a research note on Thursday, April 24th. The Goldman Sachs Group decreased their target price on RXO from $24.00 to $21.00 and set a "neutral" rating for the company in a research note on Thursday, April 10th. Benchmark restated a "hold" rating on shares of RXO in a research note on Wednesday, January 15th. Finally, Susquehanna decreased their target price on RXO from $18.00 to $13.00 and set a "negative" rating for the company in a research note on Wednesday, March 26th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $22.40.
Get Our Latest Stock Report on RXO
RXO Company Profile
(
Free Report)
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Read More

Before you consider RXO, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RXO wasn't on the list.
While RXO currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.